USA Today Article Rating

Biden wants to cover weight loss meds. RFK Jr. would rather we just eat better.

Nov 26, 2024 View Original Article
  • Bias Rating

    4% Center

  • Reliability

    70% ReliableGood

  • Policy Leaning

    8% Center

  • Politician Portrayal

    -58% Negative

Bias Score Analysis

The A.I. bias rating includes policy and politician portrayal leanings based on the author’s tone found in the article using machine learning. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral.

Sentiments

Overall Sentiment

-2% Negative

  •   Liberal
  •   Conservative
SentenceSentimentBias
Unlock this feature by upgrading to the Pro plan.

Bias Meter

Extremely
Liberal

Very
Liberal

Moderately
Liberal

Somewhat Liberal

Center

Somewhat Conservative

Moderately
Conservative

Very
Conservative

Extremely
Conservative

-100%
Liberal

100%
Conservative

Bias Meter

Contributing sentiments towards policy:

51% : The proposed rule would make an estimated 4 million Medicaid recipients and 3.4 million Americans on Medicare eligible for the drug, which can retail for over $1000 per month without coverage.
50% : On Tuesday, the Biden administration announced plans to provide coverage for costly anti-obesity medications, including Wegovy and Zepbound, for Americans enrolled in Medicare and Medicaid.Ozempic, the most commonly known weight-loss drug, was originally developed for Type-2 diabetes treatment.
40% : "We are betraying our children by letting (food) industries poison them," Kennedy said at a rally in November, after he had pulled out of the presidential election and backed Trump.

*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.

Copy link